{
  "id": 18341266,
  "title": "At ASH, drugmakers to showcase early data for three-pronged cancer therapies",
  "url": "https://urgent.news/2026/11/05/at-ash-drugmakers-to-showcase-early-data-for-three-pronged-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-05T17:09:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/ash-2026-trispecific-multiple-myeloma-johnson-johnson-abbvie/873852/"
  },
  "original_language": "en",
  "account": null,
  "summary": "J&J and AbbVie are among the companies advancing “trispecific” antibodies that could become another step forward in treatment for multiple myeloma.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}